Andrew Serafin - CHIEF STRATEGY OFFICER at Harmony Biosciences Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy Officer
Stock Symbol
HRMY on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Andrew Serafin since 11/12/2023

Holdings reported by Andrew Serafin for Harmony Biosciences Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 10K $334K $33.36 Jan 24, 2024 Direct Common Stock
Stock Option 47.8K Jan 24, 2024 Direct Common Stock

Transactions reported by Andrew Serafin for Harmony Biosciences Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.